iprindole has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barer, GR; Cope, G; Emery, CJ; Gill, G; Herget, J; Laude, E; Liu, X | 1 |
| Lüllmann, H; Lüllmann-Rauch, R; Wassermann, O | 1 |
1 review(s) available for iprindole and Lung Diseases
| Article | Year |
|---|---|
[Drug-induced phospholipid storage disease].
Topics: Adrenal Gland Diseases; Amitriptyline; Animals; Anticholesteremic Agents; Appetite Depressants; Body Weight; Cardiomyopathies; Chemical Phenomena; Chemistry; Chloroquine; Chlorphentermine; Drug Interactions; Female; Fenfluramine; Humans; Iprindole; Lipidoses; Lung Diseases; Lysosomes; Male; Phospholipids; Piperazines; Rats; Testicular Diseases; Thyroid Diseases; Triparanol | 1973 |
1 other study(ies) available for iprindole and Lung Diseases
| Article | Year |
|---|---|
Adverse pulmonary vascular effects of high dose tricyclic antidepressants: acute and chronic animal studies.
Topics: Acute Disease; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Cats; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Overdose; Imipramine; Iprindole; Lung Diseases; Pulmonary Artery; Rats; Rats, Wistar; Vascular Diseases | 2002 |